Upstream Bio, Financials
| UPB Stock | 19.19 0.26 1.34% |
Upstream |
Please note, the presentation of Upstream Bio,'s financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Upstream Bio,'s management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Upstream Bio,'s management manipulating its earnings.
Specialization | Healthcare, Biotechnology |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| CUSIP | 91678A107 |
| Location | Massachusetts; U.S.A |
| Business Address | 890 Winter Street, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | upstreambio.com |
| Phone | 781 208 2466 |
Upstream Bio, Key Financial Ratios
Upstream Bio, Systematic Risk
Upstream Bio,'s systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Upstream Bio, volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-two with a total number of output elements of thirty-four. The Beta measures systematic risk based on how returns on Upstream Bio, correlated with the market. If Beta is less than 0 Upstream Bio, generally moves in the opposite direction as compared to the market. If Upstream Bio, Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Upstream Bio, is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Upstream Bio, is generally in the same direction as the market. If Beta > 1 Upstream Bio, moves generally in the same direction as, but more than the movement of the benchmark.
About Upstream Bio, Financials
What exactly are Upstream Bio, Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Upstream Bio,'s income statement, its balance sheet, and the statement of cash flows. Potential Upstream Bio, investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Upstream Bio, investors may use each financial statement separately, they are all related. The changes in Upstream Bio,'s assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Upstream Bio,'s income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Upstream Bio, December 30, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Upstream Bio, help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Upstream Bio,. We use our internally-developed statistical techniques to arrive at the intrinsic value of Upstream Bio, based on widely used predictive technical indicators. In general, we focus on analyzing Upstream Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Upstream Bio,'s daily price indicators and compare them against related drivers.
| Downside Deviation | 6.29 | |||
| Information Ratio | 0.06 | |||
| Maximum Drawdown | 50.21 | |||
| Value At Risk | (6.88) | |||
| Potential Upside | 10.61 |
Complementary Tools for Upstream Stock analysis
When running Upstream Bio,'s price analysis, check to measure Upstream Bio,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Upstream Bio, is operating at the current time. Most of Upstream Bio,'s value examination focuses on studying past and present price action to predict the probability of Upstream Bio,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Upstream Bio,'s price. Additionally, you may evaluate how the addition of Upstream Bio, to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |